Combo GIP/GLP-1 Drug Superior for HbA1c Reduction in T2D 40-week trial compared tirzepatide head-to-head with injectable semaglutide Jun 25, 2021
Best Pediatric Endocrinology Hospitals; Standards of Diabetes Care Updated News and commentary from the endocrinology world Jun 20, 2021
Obesity Ups Risk of Erosive Esophagitis in Middle-Age Adults Japanese study researchers note it may also increase risk for GERD Jun 16, 2021
Nearly a Five-Fold Difference Between States in Use of Bariatric Surgery Weight loss procedure underutilized in areas with highest obesity prevalence Jun 13, 2021
Patients with Class I Obesity Still Benefit from Weight-Loss Surgery It may be time to update NIH-established indications for bariatric surgery, experts say Jun 12, 2021
Bariatric Surgery Tied to Decreased Stroke Risk Out to 5 Years "Clinically important" finding, says researcher Jun 11, 2021
More Insight on Which Kids Are Most at Risk for Severe COVID-19 Large database helps inform differences in pediatric illness patterns Jun 07, 2021
COVID-19 in Diabetes: What Mediates Risk? Certain clinical factors tied to higher chance of severe infection May 28, 2021
Getting Competitive Boosted Physical Activity in Diabetes Competing for top spot increased mean daily step counts in gamified study May 24, 2021
FDA Draft Guidance on T2D Devices; New GLP-1 Drug Succeeds in Trial News and commentary from the endocrinology world May 23, 2021
Poorly Controlled Sleep Apnea Tied to More COVID-19 Infections As adherence to PAP increased, infection rates fell, researcher says May 20, 2021
Probiotics Protect Overweight, Older Patients From Coughs and Wheeze Trial affirms "gut-lung" link but with important caveats May 14, 2021
Adding GLP-1 Drug Makes Sleeve Gastroplasty a Diabetes Treatment Endoscopic procedure could yield benefits now seen only with more invasive surgery May 14, 2021
Amylin Analogue Plus Semaglutide Get Early Win for Weight Loss Combining agents yielded greater weight changes than semaglutide alone May 13, 2021
Saxenda Boosted Weight Loss, Especially With Exercise But year-long RCT excluded those with type 2 diabetes May 05, 2021
Moms' Health Habits Rub Off on Children Australian study suggests young kids copy parental behavior, healthy as well as unhealthy Apr 26, 2021
Tepezza Restock Coming; Osteoporotic Fractures Broken Down by State News and commentary from the endocrinology world Apr 04, 2021
Maintenance Semaglutide Keeps Shedding the Pounds Continued weight loss beyond 1 year while on drug; patients switched to placebo gained it back Mar 23, 2021
Banned Stimulants Again Found in Supplements Researchers question FDA's commitment to enforcement Mar 23, 2021
Op-Ed: Corn Money is Expanding America's Waistline Dear AMA, please lobby for investment in healthy produce Mar 22, 2021
Hormonal IUD Shows Promise in Early Endometrial Cancer Regression seen in 82% of women with precancerous lesions Mar 21, 2021
Another Weight-Loss Trial Win for Weekly GLP-1 Drug Effective in diabetic patients with BMI as low as 27 Mar 05, 2021
GIP/GLP-1 RA Phase III Success; USPSTF Looking for Input News and commentary from the endocrinology world Feb 28, 2021
White Bread or White Rice? Glycemic Index Telling of CVD Risk Across Borders Observational study suggests role of diet in primary, secondary prevention alike Feb 24, 2021
ACC Report: Cardiac Care Better Woman-to-Woman Group suggests rethink of cardiology culture and medical education Feb 22, 2021
Semaglutide Shines as Weight Loss Therapy "Unprecedented results" for patients with obesity in 68-week trial Feb 10, 2021
Nutrition Status Tied to TAVR Outcomes Data support pre- and post-TAVR dietary interventions for the elderly Feb 05, 2021
Ozempic Seeking High Dose OK; Thyroid Cancer Overdiagnosed in Kids? News and commentary from the endocrinology world Jan 24, 2021
Monoclonal Antibody Induces Weight Loss in Type 2 Diabetes Phase II trial reported decreased fat, increased lean mass Jan 13, 2021
Young-Onset Esophageal Cancer Rapidly Increasing Physicians should be on the alert for younger patients with dysphagia, researchers urge Dec 16, 2020
New GLP-1 Agonist Succeeds in Phase III; PFAS Chemicals & COVID-19 News and commentary from the endocrinology world Dec 11, 2020
Over 73% of U.S. Adults Overweight or Obese Obesity rate up by half since 1999-2000, NHANES data indicate; nearly 10% severely obese Dec 11, 2020
Saxenda OK'd for Teens with Obesity Liraglutide label now includes adolescents as young as 12 Dec 07, 2020
COVID's Heart Complications Modest in Large Registry Obese and minority groups at higher risk, though, analyses affirm Nov 18, 2020
Trial Finds Semaglutide Resolves NASH in Many Obese Adults But "unexpected" lack of improvement in fibrosis stage vs placebo Nov 13, 2020
IBT Plus Semaglutide Slashed Pounds, CVD Risk Patients lost 16% of body weight after 68 weeks in phase III trial Nov 09, 2020
MC4 Agonist Cuts Body Weight, Hunger in Genetically-Driven Obesity Trial success raises questions about broader application Nov 04, 2020